Copyright © 1999 by the European Society of Cardiology.
Radiofrequency catheter ablation of accessory pathways. Outcome and use of antiarrhythmic drugs during follow-up
The Department of Cardiology and Angiology, Hospital of the Westfälische Wilhelms-University and Institute for Arteriosclerosis Research, Münster, Germany
revised May 28, 1999; accepted June 2, 1999
Abstract
Aims The purpose of this study was to assess the acute and long-term success of accessory pathway ablation in a single large-volume centre, concentrating on long-term recurrences and the clinical use of antiarrhythmic drugs.
Methods and Results A total of 519 consecutive patients (mean age 40±14 years) underwent radiofrequency ablation of manifest or concealed accessory pathways. The patients were seen in the hospital or by the referring physician at 6 and 12 months. Long-term follow-up information was obtained by questionnaire. Pathway conduction was abolished in 476 cases (91·7%). ‘Redo’ procedures, due to recurrence, were performed in 38 patients (7·3%) and were successful in 30 (78·9%). Follow-up data were obtained from 454 patients (87·5%) with a follow-up duration of 22·6±12·4 months. Among the 398 patients with successful ablations who responded to the questionnaire, 340 (85·4%) were asymptomatic with only 10·6% taking antiarrhythmic drugs. An additional 20 patients (5·0%) had symptoms suspicious of recurrence. In total, 66 out of 398 successfully treated patients (16·6%) were taking antiarrhythmic drugs. Twenty-three out of 56 (41·1%) patients with failed ablations were asymptomatic, 12 of whom (21·4% of patients with failed ablations) had not been administered antiarrhythmic drugs. In the total group of 454 patients with ablation attempts and available follow-up data, 99 (21·8%) were still taking antiarrhythmic drugs during follow-up.
Conclusions Patients with successful ablation of accessory pathways show excellent long-term results. However, 17% of successfully treated patients were still taking antiarrhythmic drugs during the period of long-term follow-up. On the other hand, 21% of patients with failed ablations were symptom-free without antiarrhythmic drugs. On an intention-to-treat basis, 22% of the patients with ablation attempts were still taking antiarrhythmic drugs during follow-up.
Key Words: Accessory pathway, radiofrequency current, catheter ablation
f1 Present address: Department of Cardiology, University of Essen, Germany.
f3 Correspondence: Dr Nikolaos Dagres, Abteilung fuer Kardiologie, Medizinische Klinik, Universitaetsklinikum Essen, Hufelandstr. 55, 45122 Essen, Germany. Tel: +49/201/7232339, fax: +49/201/7235951.
f2 Present address: Royal Brompton Hospital, London, U.K.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. E. Eckart and L. M. Epstein Interventional Therapy for Atrial and Ventricular Arrhythmias Card. Surg. Adult, January 1, 2008; 3(2008): 1357 - 1374. [Full Text]
|
|
|
|
 |
|
 N. Dagres, C. Piorkowski, H. Kottkamp, D. Th. Kremastinos, and G. Hindricks Contemporary catheter ablation of arrhythmias in geriatric patients: patient characteristics, distribution of arrhythmias, and outcome Europace, July 1, 2007; 9(7): 477 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F G Cosio Should ablation be the first line treatment for supraventricular arrhythmias? Heart, January 1, 2005; 91(1): 5 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Dagres, J. R. Clague, G. Breithardt, and M. Borggrefe Significant gender-related differences in radiofrequency catheter ablation therapy J. Am. Coll. Cardiol., September 17, 2003; 42(6): 1103 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Satti and L. M. Epstein Cardiologic Interventional Therapy for Atrial and Ventricular Arrhythmias Card. Surg. Adult, January 1, 2003; 2(2003): 1253 - 1270. [Full Text]
|
|
|
|
 |
|
 J Schlapfer and M Fromer Late clinical outcome after successful radiofrequency catheter ablation of accessory pathways Eur. Heart J., April 1, 2001; 22(7): 605 - 609. [Abstract] [PDF]
|
|
|
|
|
|
N Dagres, J.R Clague, H Lottkamp, G Hindricks, G Breithardt, and M Borggrefe Impact of radiofrequency catheter ablation of accessory pathways on the frequency of atrial fibrillation during long-term follow-up; High recurrence rate of atrial fibrillation in patients older than 50 years of age Eur. Heart J., March 1, 2001; 22(5): 423 - 427. [Abstract] [PDF]
|
|